Dr. Fauci is as wildly enthusiastic about remdesivir after one positive study as he is wildly pessimistic about hydroxychloroquine after many positive studies.
-
-
results from a Chinese trial were published today. Smaller trial, some apparent benefits (faster time to recovery, lower mortality) but generally not statistically significant. US data are actually pretty similar but with more patients the benefit is statistically significant
-
in both cases, patients probably getting the treatment later in the disease course than is optimal. Ongoing trials are looking into use in milder patients earlier on
- 2 more replies
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.
